Restless legs syndrome and sleep-related disorders

Giacomo Della Marca, Alberto Albanese

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

History “Wherefore to some, when being at bed they betake themselves to sleep, presently in the arms and legs leapings and contractions to the tendons, and so great restlessness and tossing of their members ensue, that the diseased are no more able to sleep than if they were in a place of the greatest torture” [1]. Thomas Willis provided in 1672 what is thought to be the first clinical description of restless legs syndrome (RLS), which would be considered as a distinct clinical entity only centuries later, when Ekbom commented: “The syndrome is so common and causes such suffering, that it should be known to every physician” [2]. Following this seminal paper, RLS has also been known as Ekbom syndrome. This peculiar symptomatology has since attracted the interest of physicians but it has remained an elusive entity because of diagnostic uncertainties. The link between iron and RLS was formally made in 1953 when Nordlander put forward the theory that iron insufficiency caused RLS, and used large doses of intravenous iron to treat it [3]. More recently, evidence of the involvement of the dopaminergic system (in particular the deficiency of dopamine D2 receptors) suggested the use of dopaminergic agonists in the treatment of RLS, which proved to be highly effective [4]. In 2006, the US Food and Drug Administration (FDA) approved the use of pramipexole for the treatment of moderate to severe RLS. In 1995, the International Restless Legs Syndrome Study Group (IRLSSG) established consensus diagnostic criteria [5], which were further revised in 2003 [6]

Original languageEnglish
Title of host publicationUncommon Causes of Movement Disorders
PublisherCambridge University Press
Pages108-120
Number of pages13
ISBN (Print)9780511977749, 9780521111546
DOIs
Publication statusPublished - Jan 1 2011

Fingerprint

Restless Legs Syndrome
Iron
Sleep
Torture
Physicians
Psychomotor Agitation
Dopamine D2 Receptors
Dopamine Agonists
United States Food and Drug Administration
Sleep Wake Disorders
Psychological Stress
Tendons
Uncertainty
Leg
Consensus
Arm
History
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Marca, G. D., & Albanese, A. (2011). Restless legs syndrome and sleep-related disorders. In Uncommon Causes of Movement Disorders (pp. 108-120). Cambridge University Press. https://doi.org/10.1017/CBO9780511977749.011

Restless legs syndrome and sleep-related disorders. / Marca, Giacomo Della; Albanese, Alberto.

Uncommon Causes of Movement Disorders. Cambridge University Press, 2011. p. 108-120.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marca, GD & Albanese, A 2011, Restless legs syndrome and sleep-related disorders. in Uncommon Causes of Movement Disorders. Cambridge University Press, pp. 108-120. https://doi.org/10.1017/CBO9780511977749.011
Marca GD, Albanese A. Restless legs syndrome and sleep-related disorders. In Uncommon Causes of Movement Disorders. Cambridge University Press. 2011. p. 108-120 https://doi.org/10.1017/CBO9780511977749.011
Marca, Giacomo Della ; Albanese, Alberto. / Restless legs syndrome and sleep-related disorders. Uncommon Causes of Movement Disorders. Cambridge University Press, 2011. pp. 108-120
@inbook{c7c797925c2642ed81e2d3ce3122e0cd,
title = "Restless legs syndrome and sleep-related disorders",
abstract = "History “Wherefore to some, when being at bed they betake themselves to sleep, presently in the arms and legs leapings and contractions to the tendons, and so great restlessness and tossing of their members ensue, that the diseased are no more able to sleep than if they were in a place of the greatest torture” [1]. Thomas Willis provided in 1672 what is thought to be the first clinical description of restless legs syndrome (RLS), which would be considered as a distinct clinical entity only centuries later, when Ekbom commented: “The syndrome is so common and causes such suffering, that it should be known to every physician” [2]. Following this seminal paper, RLS has also been known as Ekbom syndrome. This peculiar symptomatology has since attracted the interest of physicians but it has remained an elusive entity because of diagnostic uncertainties. The link between iron and RLS was formally made in 1953 when Nordlander put forward the theory that iron insufficiency caused RLS, and used large doses of intravenous iron to treat it [3]. More recently, evidence of the involvement of the dopaminergic system (in particular the deficiency of dopamine D2 receptors) suggested the use of dopaminergic agonists in the treatment of RLS, which proved to be highly effective [4]. In 2006, the US Food and Drug Administration (FDA) approved the use of pramipexole for the treatment of moderate to severe RLS. In 1995, the International Restless Legs Syndrome Study Group (IRLSSG) established consensus diagnostic criteria [5], which were further revised in 2003 [6]",
author = "Marca, {Giacomo Della} and Alberto Albanese",
year = "2011",
month = "1",
day = "1",
doi = "10.1017/CBO9780511977749.011",
language = "English",
isbn = "9780511977749",
pages = "108--120",
booktitle = "Uncommon Causes of Movement Disorders",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Restless legs syndrome and sleep-related disorders

AU - Marca, Giacomo Della

AU - Albanese, Alberto

PY - 2011/1/1

Y1 - 2011/1/1

N2 - History “Wherefore to some, when being at bed they betake themselves to sleep, presently in the arms and legs leapings and contractions to the tendons, and so great restlessness and tossing of their members ensue, that the diseased are no more able to sleep than if they were in a place of the greatest torture” [1]. Thomas Willis provided in 1672 what is thought to be the first clinical description of restless legs syndrome (RLS), which would be considered as a distinct clinical entity only centuries later, when Ekbom commented: “The syndrome is so common and causes such suffering, that it should be known to every physician” [2]. Following this seminal paper, RLS has also been known as Ekbom syndrome. This peculiar symptomatology has since attracted the interest of physicians but it has remained an elusive entity because of diagnostic uncertainties. The link between iron and RLS was formally made in 1953 when Nordlander put forward the theory that iron insufficiency caused RLS, and used large doses of intravenous iron to treat it [3]. More recently, evidence of the involvement of the dopaminergic system (in particular the deficiency of dopamine D2 receptors) suggested the use of dopaminergic agonists in the treatment of RLS, which proved to be highly effective [4]. In 2006, the US Food and Drug Administration (FDA) approved the use of pramipexole for the treatment of moderate to severe RLS. In 1995, the International Restless Legs Syndrome Study Group (IRLSSG) established consensus diagnostic criteria [5], which were further revised in 2003 [6]

AB - History “Wherefore to some, when being at bed they betake themselves to sleep, presently in the arms and legs leapings and contractions to the tendons, and so great restlessness and tossing of their members ensue, that the diseased are no more able to sleep than if they were in a place of the greatest torture” [1]. Thomas Willis provided in 1672 what is thought to be the first clinical description of restless legs syndrome (RLS), which would be considered as a distinct clinical entity only centuries later, when Ekbom commented: “The syndrome is so common and causes such suffering, that it should be known to every physician” [2]. Following this seminal paper, RLS has also been known as Ekbom syndrome. This peculiar symptomatology has since attracted the interest of physicians but it has remained an elusive entity because of diagnostic uncertainties. The link between iron and RLS was formally made in 1953 when Nordlander put forward the theory that iron insufficiency caused RLS, and used large doses of intravenous iron to treat it [3]. More recently, evidence of the involvement of the dopaminergic system (in particular the deficiency of dopamine D2 receptors) suggested the use of dopaminergic agonists in the treatment of RLS, which proved to be highly effective [4]. In 2006, the US Food and Drug Administration (FDA) approved the use of pramipexole for the treatment of moderate to severe RLS. In 1995, the International Restless Legs Syndrome Study Group (IRLSSG) established consensus diagnostic criteria [5], which were further revised in 2003 [6]

UR - http://www.scopus.com/inward/record.url?scp=84927015626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927015626&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511977749.011

DO - 10.1017/CBO9780511977749.011

M3 - Chapter

SN - 9780511977749

SN - 9780521111546

SP - 108

EP - 120

BT - Uncommon Causes of Movement Disorders

PB - Cambridge University Press

ER -